VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 118 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.52 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $781,000 | +12.9% | 41,000 | 0.0% | 0.56% | +77.6% |
| Q1 2018 | $692,000 | -38.6% | 41,000 | -44.6% | 0.31% | -36.3% |
| Q4 2017 | $1,127,000 | -14.8% | 74,000 | 0.0% | 0.49% | +2.9% |
| Q3 2017 | $1,323,000 | +9.9% | 74,000 | 0.0% | 0.48% | +3.0% |
| Q2 2017 | $1,204,000 | +16.4% | 74,000 | 0.0% | 0.46% | +18.4% |
| Q1 2017 | $1,034,000 | +24.4% | 74,000 | +42.3% | 0.39% | -16.3% |
| Q4 2016 | $831,000 | -3.9% | 52,000 | 0.0% | 0.47% | -10.2% |
| Q3 2016 | $865,000 | +48.6% | 52,000 | 0.0% | 0.52% | +10.9% |
| Q2 2016 | $582,000 | +34.1% | 52,000 | 0.0% | 0.47% | +225.7% |
| Q1 2016 | $434,000 | +19.6% | 52,000 | +33.3% | 0.14% | -26.5% |
| Q4 2015 | $363,000 | -70.4% | 39,000 | -64.2% | 0.20% | -66.0% |
| Q3 2015 | $1,228,000 | +148.1% | 109,000 | +179.5% | 0.58% | +260.0% |
| Q2 2015 | $495,000 | – | 39,000 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,658,759 | $121,733,000 | 8.95% |
| Palo Alto Investors LP | 4,155,670 | $108,588,000 | 5.78% |
| Stonepine Capital Management, LLC | 220,848 | $5,771,000 | 5.07% |
| Birchview Capital, LP | 80,000 | $2,090,000 | 1.98% |
| EAM Global Investors LLC | 75,310 | $1,968,000 | 1.08% |
| Atika Capital Management LLC | 130,000 | $3,397,000 | 1.00% |
| EAM Investors, LLC | 110,806 | $2,895,000 | 0.79% |
| UNIVERSITY OF NOTRE DAME DU LAC | 97,521 | $2,548,000 | 0.62% |
| ALGERT GLOBAL LLC | 76,204 | $1,991,000 | 0.56% |
| 361 CAPITAL LLC | 85,885 | $2,244,000 | 0.46% |